Skip to content
TrialScanner

NCT04553406

Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Phase 2TerminatedSPROLead

Registry record

Lead sponsor
Spero Therapeutics
Conditions
Mycobacterium Avium Complex; Non-tuberculous Mycobacterium Pulmonary Disease
Primary completion
Jan 28, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04553406 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04553406: Safety, Tolerability... | TrialScanner